Crossmatch Testing(1535)Zachary Moore
What Are the Challenges in the Routine Implementation of VXM Testing? For patients who do not have HLA antibodies by SAB assay, pretransplant PXM may be unnecessary, irrespective of the HLA type of the potential donor, provided there were not any recent sensitizing events in the recipient. Alth...
RegisterLog in Sign up with one click: Facebook Twitter Google Share on Facebook major crossmatch The testing of a recipient’s serum against potential donor red cells to detect ABO incompatibility and other major antibodies. Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved...
doi:10.1016/0198-8859(94)91782-5R BUELOWHuman ImmunologyBuelow R, Chiang TR, Monteiro F, et al. Soluble HLA antigens and ELISA: a new technology for panel reactive antibody and crossmatch testing. Transplantation 1995; 60(12): 1594.
Performing serologic tests for unexpected alloantibodies and donor-recipient compatibility without an "immediate-spin" or room-temperature phase abbreviates pretransfusion testing and reduces the detection of clinically insignificant alloantibodies solely reactive at room temperature....
The influence of crossmatching in liver transplantation is still controversial, and at present, our unit does not alter management according to the result of standard lymphocytotoxicity testing. This study retrospectively assessed outcome of grafts transplanted in the presence of preformed antidonor ...
CrossmatchTubes are available in two versions. The ZCrossmatchSerumClot Activator Tube contains a clottingactivator and is suitable forcrossmatchtests when serum is required for testing material. The K3ECrossmatchK3EDTATube is suitable when the testing material required is blood cells. ...
CrossmatchTubes are available in two versions. The ZCrossmatchSerumClot Activator Tube contains a clottingactivator and is suitable forcrossmatchtests when serum is required for testing material. The K3ECrossmatchK3EDTATube is suitable when the testing material required is blood cells. ...
Motivated by the need to eliminate testing that does not significantly enhance the provision of a safe product, the necessity for doing crossmatches has been questioned. Recent studies indicate that the substitution of the “group-and-screen” for the complete crossmatch represents an ...
All sera were treated with hypotonic dialysis or Melon Column prior to testing to remove prozone interference. Results The new kidney allocation system has increased the use of VXMs to assess donor compatibility prior to acceptance of imported organs. During the month of November 2016, 111 VXMs ...